Purchase Order 75A50119P00023
Award Date
5/1/19
Potential Completion Date
8/31/19
Potential Value
$132K
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for WETVAX POTENCY TESTING. The contract has a potential value of $136,612.00 and is a Firm Fixed Price Purchase Order. The place of performance is Canton, MA 02021, USA. The contract does not have a set-aside designation. As the awardee, Emergent Biodefense Operations Lansing LLC is a for-profit...
<p>This is a contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Emergent Biodefense Operations Lansing LLC, also known as Emergent Biodefense, for the maintenance of a smallpox license. The contract is a delivery order with a firm fixed price of $38,430,000.00 and a completion date of January 31, 2019. The place of performance is located in Cambridge, Massachusetts. The contract does not have a set-aside designation.</p>
The U.S. Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $630,384,987.00 firm-fixed-price definitive contract to Emergent BioDefense Operations Lansing LLC for the advanced research and development of a smallpox antiviral drug. This award is not associated with a set-aside contract and is part of ASPR's broader efforts to procure and stockpile alternative smallpox antivirals. The original procurement was...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for the WETVAX 2021 project. The contract has a potential value of $141,400.00 and a completion date of August 31, 2021. The contract does not have a set-aside designation. Emergent Biodefense Operations Lansing LLC is the prime contractor for this award, which is likely related to the agency's...
This is a $748,857,151.46 firm fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer, to develop and deliver the ACAM2000 smallpox (vaccinia) vaccine over a 10-year period. The contract was awarded on a sole-source basis as Emergent is the only FDA-licensed provider of ACAM2000. This contract does not have a set-aside...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for vaccine potency testing services. The $127,526.00 contract has a completion date of November 30, 2018 and was awarded on August 31, 2018. The place of performance is Lansing, Michigan. Emergent Biodefense Operations Lansing LLC is a for-profit manufacturer. This contract was not set aside for any particular...
<p>This is a $135,895.50 firm fixed price purchase order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for the annual potency testing of the WETVAX (APSV) vials stored at the Strategic National Stockpile (SNS). The contract has an end date of August 31, 2022 and was awarded on May 12, 2022. No set-aside was used for this procurement.</p>
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...
This firm fixed-price contract, valued at $762,812,695, was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company. The contract is for the development of medical countermeasures (MCM) that can be deployed in the event of a filovirus outbreak, which is a crucial component of the U.S. government's outbreak response...
<p>This is a firm fixed-price delivery order contract for $838,800.00 awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Biologics, LLC, a foreign-owned for-profit organization, to provide smallpox diluent. The contract has an ultimate completion date of July 6, 2017 and was awarded on May 18, 2016. There is no set-aside designation mentioned for this contract.</p>